Cubist Systematic Strategies’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Cubist Systematic Strategies’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-520	Closed	-$9K	–	2426
2018 Q3	$9K	Buy	+520	New	+$8.93K	﹤0.01%	1828

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Cubist Systematic Strategies's ECYT Position: Q4 2018 in Review

Cubist Systematic Strategies sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 520 shares — an estimated $9K sold.

Cubist Systematic Strategies first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $9K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Cubist Systematic Strategies reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Cubist Systematic Strategies sold 520 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $9K.
Cubist Systematic Strategies first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
Cubist Systematic Strategies's Endocyte, Inc. Common Stock position peaked at $9K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Cubist Systematic Strategies's 13F filing for Q4 2018, filed 14 Feb 2019.